| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |